Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate

Affiliations

• ¹ University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado, USA.
• ² Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ³ Division of Medical Oncology, University of Colorado, School of Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA.
• ⁴ Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
• ⁵ German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (CPC-M), Neuherberg, Germany.